How weight-loss drugs trounced a luxury giant, explained : vimarsana.com

Last week, Danish pharma major Novo Nordisk dethroned French luxury giant LVMH to emerge as Europe’s most valued company. The secret? Humanity’s insatiable appetite for two weight-loss drugs, Ozempic and Wegovy. Mint explains the obesity crisis the world is facing.

Related Keywords

India , United Kingdom , Eli Lilly Mounjaro , United Kingdom National Health Service , Novo Nordisk , Mohan Diabetes Specialities Centre , World Health Organization , Indian Council Of Medical Research , National Health Service , Eli Lilly , Indian Council , Diabetes Specialities , Ozempic , Wegovy , Weight Loss , Diabetes , Drug , Diabetes Drug , Weight Loss Dru , Lvmh , Demark , Pharma , Danish Pharma , French Luxury , Luxury ,